SCHEMBL8375797

SCHEMBL8375797

CCOC(=O)C(Br)=C(Br)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 2/20 0.44
CYP19A1 P11511 1/20 0.44
TSHR P16473 2/20 0.43
ABCB11 O95342 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR2A P28223 1/20 0.43
PMP22 Q01453 1/20 0.43
PPARA Q07869 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
GSK3B P49841 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375792 1.00 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1GAATDP1MAPT
SCHEMBL8375080 0.84 LMNA (0.43) SMN1; SMN2ALDH1A1GAAMAPTCYP1A2
SCHEMBL8375083 0.84 LMNA (0.43) SMN1; SMN2ALDH1A1GAAMAPTCYP1A2
SCHEMBL11821119 0.83 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1GAATDP1MAPT
SCHEMBL1054614 0.83 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1GAATDP1MAPT
SCHEMBL8375834 0.80 NPSR1 (0.51) ALDH1A1MAPTCES2CES1GSK3B
SCHEMBL8375832 0.80 NPSR1 (0.51) ALDH1A1MAPTCES2CES1GSK3B
SCHEMBL1525403 0.79 CES2 (0.57) SMN1; SMN2ALDH1A1GAATDP1MAPT
SCHEMBL8377288 0.78 NPC1 (0.51) SMN1; SMN2ALDH1A1MAPTPPARAKMT2A
SCHEMBL8377289 0.78 NPC1 (0.51) SMN1; SMN2ALDH1A1MAPTPPARAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed